we demonstrated a significant permeability barrier to clavulanic acid and sulbactam , which resulted in loss of synergism between these clinically employed beta-lactamase inhibitors and beta-lactam drugs .
C0038665
sulbactam
C1373040
beta-lactamase inhibitors